“Our Mission is to develop innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers.”
© 2020 Intra-Cellular Therapies, Inc. All rights reserved.
CAPLYTA is a registered trademark and LYTAlink is a trademark of Intra-Cellular Therapies, Inc.
The Montana Psychiatry Conference makes every attempt to provide accurate and timely content available for users. Neither MPC nor third-party content providers are responsible or liable for any such content, including advertising, products or other materials available through third party sites.